Bull case
IBM would need investors to value it at roughly 28x earnings — about 8x more generous than today's 20x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where IBM stock could go
IBM would need investors to value it at roughly 28x earnings — about 8x more generous than today's 20x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
This is close to how the market is already pricing IBM — at roughly 21x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 7x multiple contraction could push IBM down roughly 34% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

International Business Machines Corporation is a global technology company that provides integrated enterprise solutions and services. It generates revenue primarily through software (~30%), consulting (~30%), and infrastructure (~25%) segments, with financing making up the remainder. IBM's key competitive advantage lies in its deep enterprise relationships, hybrid cloud expertise—particularly through its Red Hat acquisition—and legacy mainframe business that creates significant switching costs for large corporate clients.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $2.80/$2.65 | +5.7% | $17.0B/$16.6B | +2.3% |
| Q4 2025 | $2.65/$2.45 | +8.2% | $16.3B/$16.1B | +1.5% |
| Q1 2026 | $4.52/$4.31 | +4.9% | $19.7B/$19.2B | +2.6% |
| Q2 2026 | $1.91/$1.81 | +5.5% | $15.9B/$15.6B | +1.8% |
IBM beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $115 — implies -53.8% from today's price.
| Metric | IBM | S&P 500 | Technology | 5Y Avg IBM |
|---|---|---|---|---|
| Forward PE | 20.0x | 18.8x | 22.3x | — |
| Trailing PE | 22.3x | 24.4x | 29.0x-23% | 36.0x-38% |
| PEG Ratio | 1.80x | 1.66x | 1.51x+20% | — |
| EV/EBITDA | 18.7x | 15.2x+23% | 16.6x+13% | 15.8x+19% |
| Price/FCF | 20.2x | 20.7x | 19.2x | 16.3x+24% |
| Price/Sales | 3.5x | 3.1x+12% | 2.4x+42% | 2.8x+23% |
| Dividend Yield | 2.65% | 1.91% | 1.11% | 3.74% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolIBM generates $13.1B in free cash flow at a 19.0% margin — returns 2.6% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~4.1 years to full repayment at current FCF run-rate
* Elevated by buyback-compressed equity — compare ROIC (9.8%) for an undistorted picture of capital efficiency.
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
IBM has historically shown significant drawdowns during market shocks, averaging -16% across 15 major systemic shocks.
Morgan Stanley maintained a cautious stance on IBM post-Q2 earnings, reiterating an Equal-Weight rating and $253 price target.
IBM's stock recently experienced a significant decrease in the market, reflecting bearish investor sentiment.
IBM's hybrid cloud and AI strategy faces scrutiny as it aims to lead by 2026, with investor focus on execution risks.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
IBM announced a more than US$10.00 billion five-year quantum computing investment, signaling strong commitment to cutting-edge technology.
IBM unveiled new enterprise AI and hybrid cloud products, including upgrades to watsonx Orchestrate, enhancing its competitive edge.
IBM expanded collaborations with ServiceNow, Google Cloud, and others to modernize enterprise IT and AI adoption.
IBM's wide moat and institutional ownership, including top holder Vanguard Group (9%), underscore its market resilience.
IBM's focus on workforce upskilling programs supports long-term innovation and operational efficiency.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
IBM IBM International Business Machines Corporation | $233.7B | 20.0x | +3.7% | 15.6% | Hold | +25.0% |
ACN ACN Accenture plc | $80.3B | 9.4x | +4.6% | 10.7% | Buy | +81.0% |
HPE HPE Hewlett Packard Enterprise Company | $62.8B | 13.9x | +8.3% | 3.9% | Hold | +46.1% |
DXC DXC DXC Technology Company | $1.4B | 2.7x | +0.1% | 0.1% | Hold | +59.0% |
CTS CTSH Cognizant Technology Solutions Corporation | $20.7B | 7.6x | +6.4% | 10.4% | Hold | +78.3% |
INF INFY Infosys Limited | $42.9B | 13.9x | +4.0% | 16.2% | Hold | +59.9% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
IBM returns 2.6% total yield, led by a 2.65% dividend, raised 30 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $3.37 | — | — | — |
| 2025 | $6.71 | +0.6% | 0.0% | 2.2% |
| 2024 | $6.67 | +0.6% | 0.0% | 3.0% |
| 2023 | $6.63 | +0.6% | 0.3% | 4.3% |
| 2022 | $6.59 | +4.0% | 0.3% | 4.9% |
Common questions answered from live analyst data and company financials.
International Business Machines Corporation (IBM) is rated Hold by Wall Street analysts as of 2026. Of 50 analysts covering the stock, 23 rate it Buy or Strong Buy, 23 rate it Hold, and 4 rate it Sell or Strong Sell. The consensus 12-month price target is $311, implying +25.0% from the current price of $249. The bear case scenario is $165 and the bull case is $345.
The Wall Street consensus price target for IBM is $311 based on 50 analyst estimates. The high-end target is $360 (+44.5% from today), and the low-end target is $225 (-9.7%). The base case model target is $262.
IBM trades at 20.0x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for IBM in 2026 are: (1) Market Volatility Sensitivity — IBM has historically shown significant drawdowns during market shocks, averaging -16% across 15 major systemic shocks. (2) Earnings Performance Concerns — Morgan Stanley maintained a cautious stance on IBM post-Q2 earnings, reiterating an Equal-Weight rating and $253 price target. (3) Stock Price Decline — IBM's stock recently experienced a significant decrease in the market, reflecting bearish investor sentiment. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates IBM will report consensus revenue of $71.5B (+3.7% year-over-year) and EPS of $10.85 (-3.9% year-over-year) for the upcoming fiscal year. The following year, analysts project $74.7B in revenue.
International Business Machines Corporation is expected to report its next earnings on approximately 2026-07-22. Consensus expects EPS of $3.01 and revenue of $17.8B. Over recent quarters, IBM has beaten EPS estimates 100% of the time.
International Business Machines Corporation (IBM) generated $13.1B in free cash flow over the trailing twelve months — a free cash flow margin of 19.0%. IBM returns capital to shareholders through dividends (2.6% yield) and share repurchases ($0 TTM).